After decades of quiet toil in laboratories, novel drugs are emerging that could rewrite the rules of old age, how we define long life and, ultimately, how we organise as a society. Full article
This author has yet to write their bio.Meanwhile lets just say that we are proud dpagano contributed a whooping 42 entries.
Entries by dpagano
The Sunday Times’ tech correspondent Danny Fortson talks to the scientists and executives pledging to redefine life as we know it about why we may be finally on the cusp of an age revolution, taking the pain out of being old, the wonder drugs already in circulation, on whether we are playing god, the rejuvenating […]
Is it real or science fiction to dream of being able to treat… getting old? In this episode, we discuss with Dr. Thomas Rando from Stanford (who directs the Glenn Center for the Biology of Aging), Kristen Fortney, CEO of BioAge, and a16z’s general partner Vijay Pande where we are in the field of “geroscience” […]
Major traumatic events such as landmine explosions can rip away whole chunks of tissue and make it difficult or impossible to ever regain function. In the face of such complete devastation, even muscle stem cells falter. Now Stanford neurologist Thomas Rando, MD, PhD, and former postdoctoral scholar Marco Quarta, PhD, have outlined a three-part approach that, at least […]
What if we could end aging and prevent age-related diseases? Joseph Pace and guests explore recent advances in aging and longevity research. Listen to the interview